Correlation Between Seres Therapeutics and Vincerx Pharma
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Vincerx Pharma, you can compare the effects of market volatilities on Seres Therapeutics and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Vincerx Pharma.
Diversification Opportunities for Seres Therapeutics and Vincerx Pharma
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Seres and Vincerx is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Vincerx Pharma go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Vincerx Pharma
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.03 times more return on investment than Vincerx Pharma. However, Seres Therapeutics is 1.03 times more volatile than Vincerx Pharma. It trades about 0.09 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.2 per unit of risk. If you would invest 78.00 in Seres Therapeutics on September 3, 2024 and sell it today you would earn a total of 20.00 from holding Seres Therapeutics or generate 25.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Vincerx Pharma
Performance |
| Timeline |
| Seres Therapeutics |
| Vincerx Pharma |
Seres Therapeutics and Vincerx Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Vincerx Pharma
The main advantage of trading using opposite Seres Therapeutics and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.| Seres Therapeutics vs. DiaMedica Therapeutics | Seres Therapeutics vs. Lyra Therapeutics | Seres Therapeutics vs. Centessa Pharmaceuticals PLC |
| Vincerx Pharma vs. DiaMedica Therapeutics | Vincerx Pharma vs. Lyra Therapeutics | Vincerx Pharma vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |